Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer's disease

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1816-1823

  Kloskowska, Ewa ^a   Pham, Therese M ^a   Nilsson, Tatjana ^a   Zhu, Shunwei ^a   Öberg, Johanna ^a   Codita, Alina ^a   Pedersen, Lars Ø ^b   Pedersen, Jan T ^b   Malkiewicz, Katarzyna ^a   Winblad, Bengt ^a   Folkesson, Ronnie ^a   Benedikz, Eirikur ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b H LUNDBECK A S   (Denmark)

Author keywords

Alzheimer's disease; Animal model; Behaviour; Rat; Transgenic

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; DISEASE MODEL; HIPPOCAMPUS; HUMAN; MALE; MAZE TEST; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; RAT; SYNAPSE; TRANSGENIC RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CEREBRAL CORTEX; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MAZE LEARNING; NEURONS; PHOSPHORYLATION; RATS; RATS, TRANSGENIC; SYNAPSES; TAU PROTEINS;

ANIMALIA; RATTUS;

EID: 77955131253     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00809.x     Document Type: Article

References (36)

1. Almkvist O. Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol Scand Suppl. 1996, 165:63-71.
2. Xie Z, Tanzi RE. Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol. 2006, 41:346-59.
3. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001, 81:741-66.
4. Duyckaerts C, Potier MC, Delatour B. Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol. 2008, 115:5-38.
5. Abbott A. Laboratory animals: the Renaissance rat. Nature. 2004, 428:464-6.
6. Ruiz-Opazo N, Kosik KS, Lopez LV. Attenuated hippocampus-dependent learning and memory decline in transgenic TgAPPswe Fischer-344 rats. Mol Med. 2004, 10:36-44.
7. Vercauteren FG, Clerens S, Roy L. Early dysregulation of hippocampal proteins in transgenic rats with Alzheimer's disease-linked mutations in amyloid precursor protein and presenilin 1. Brain Res Mol Brain Res. 2004, 132:241-59.
8. Lopez EM, Bell KF, Ribeiro-da-Silva A, Cuello AC. Early changes in neurones of the hippocampus and neocortex in transgenic rats expressing intracellular human Aβ. J Alzheimers Dis. 2004, 6:421-31.
9. Echeverria V, Ducatenzeiler A, Dowd E. Altered mitogen-activated protein kinase signalling, tau hyperphosphorylation and mild spatial learning dysfunction in transgenic rats expressing β-amyloid peptide intracellularly in hippocampal and cortical neurons. Neuroscience. 2004, 129:583-92.
10. Echeverria V, Ducatenzeiler A, Alhonen L. Rat transgenic models with a phenotype of intracellular Aβ accumulation in hippocampus and cortex. J Alzheimers Dis. 2004, 6:209-19.
11. Clarke J, Thornell A, Corbett D. Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. Eur J Neurosci. 2007, 26:1845-52.
12. Flood DG, Lin YG, Lang DM. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition. Neurobiol Aging. 2009, 7:1078-90.
13. Folkesson R, Malkiewicz K, Kloskowska E. A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation. Biochem Biophys Res Commun. 2007, 358:777-82.
14. Mullan M, Crawford F, Axelman K. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992, 1:345-7.
15. Lannfelt L, Bogdanovic N, Appelgren H. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett. 1994, 168:254-6.
16. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984, 11:47-60.
17. Wimmer B, Friedburg H, Hennig J, Kauffmann GW. Diagnostic imaging potentialities of nuclear resonance tomography. Changes in vertebrae, ligaments and intervertebral disks in comparison with computed tomography. Radiologe. 1986, 26:137-43.
18. Paxinos G, Watson C. The rat brain in stereotaxic coordinates 1986, 2nd ed, San Diego, Academic Press, Inc.
19. Mayhew TM. A review of recent advances in stereology for quantifying neural structure. J Neurocytol. 1992, 21:313-28.
20. Nilsson T, Malkiewicz K, Gabrielsson M. Antibody-bound amyloid precursor protein upregulates ornithine decarboxylase expression. Biochem Biophys Res Commun. 2006, 341:1294-9.
21. Morgan D, Gordon MN. Amyloid, hyperactivity, and metabolism: theoretical comment on Vloeberghs et al. (2008). Behav Neurosci. 2008, 122:730-2.
22. Ingram DK. Age-related decline in physical activity: generalization to nonhumans. Med Sci Sports Exerc. 2000, 32:1623-9.
23. Haass C, Lemere CA, Capell A. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med. 1995, 1:1291-6.
24. Zahorsky-Reeves J, Lawson G, Chu DK. Maintaining longevity in a triple transgenic rat model of Alzheimer's disease. J Am Assoc Lab Anim Sci. 2007, 46:124.
25. Ferreira ST, Vieira MN, De Felice FG. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life. 2007, 59:332-45.
26. Edison P, Archer HA, Hinz R. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007, 68:501-8.
27. Holmes C, Boche D, Wilkinson D. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial. Lancet. 2008, 372:216-23.
28. Treit D, Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav. 1998, 31:959-62.
29. Liu L, Orozco IJ, Planel E. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol Dis. 2008, 31:46-57.
30. Sadile AG. Long-term habituation of theta-related activity components of albino rats in the làt-maze. Motor activity and movement disorders 1996, 3-55. Sanberg PROssenkopp KPKovaliers M. In, editors, New York, Humana Press, pp
31. Levinoff EJ, Li KZ, Murtha S, Chertkow H. Selective attention impairments in Alzheimer's disease: evidence for dissociable components. Neuropsychology. 2004, 18:580-8.
32. Deacon RMJ, Koros E, Bornemann KD, Rawlins JNP. Aged Tg 2576 mice are impaired on social memory and open field habituation tests. Behav Brain Res 2009, 197:466-8.
33. Lesné S, Koh MT, Kotilinek L. A specific amyloid-β protein assembly in the brain impairs memory. Nature. 2006, 440:352-7.
34. Palop JJ, Chin J, Mucke L. A network dysfunction perspective on neurodegenerative diseases. Nature. 2006, 443:768-73.
35. Kloskowska E, Malkiewicz K, Winblad B. APPswe mutation increases the frequency of spontaneous Ca(2+)-oscillations in rat hippocampal neurons. Neurosci Lett. 2008, 436:250-4.
36. Kloskowska E, Bruton JD, Winblad B, Benedikz E. The APP670/671 mutation alters calcium signaling and response to hyperosmotic stress in rat primary hippocampal neurons. Neurosci Lett. 2008, 444:275-9.